RNSG 1301 EXAM ONE EXAM WITH
COMPLETE SOLUTIONS
Generic drugs - ANSdrugs sold by their generic name; not brand (or trade) name
products
Brand name - ANSname given to a drug by the pharmaceutical company that
developed it; also called a trade name
Genetic drugs vs Brand name - ANSOnce the patent on a brand name runs out
manufactures develop genetic drugs which are intended work on in the same way
(quality, dosage, strength, and route of administration).
The bioavailability of the generic drugs may differ from the brand name. This is why
providers might specify "dispense as written" so brand name product may use
especially in drugs that have narrow safety margins.
Control substance - (C-I) Schedule I - ANSHigh abuse potential and no accepted
medical use (heroin, marijuana, LSD)
Control substance - (C-II) Schedule II - ANSHigh abuse potential with severe
dependence liability (narcotics, amphetamines, and barbiturates)
Example: Cocaine, methamphetamines, methadone, Dilaudid, Demerol, Oxycodone,
Fentanyl, Morphine, Adderall, Ritalin, Dexedrine.
Written prescription only, no refills
Control substance - (C-III) Schedule III - ANSLess abuse potential than schedule II
drugs and moderate dependence liability (nonbarbiturate sedatives, nonamphetamine
stimulants, limited amounts of certain narcotics)
< 15 mg hydrocodone per dosage unit (Vicodin) ; < 90 mg of codeine p3er dosage unit
(Tylenol w/ codeine); ketamine; anabolic steroids; testosterone
Written/Oral Rx that expired w/n 6mos. No more than 5 refills.
, Control substance - (C-IV) Schedule IV - ANSLess abuse potential than schedule III and
limited dependence liability (some sedatives, antianxiety agents, and nonnarcotic
analgesics)
Examples: Xanax, Soma, Valium, Ativan, Talwin, Ambien
Written/Oral Rx that expires w/n 6 mons. No more than 5 refills.
Control substance - (C-V) Schedule V - ANSLimited abuse potential
Cough suppressants < 200 mg codeine/100 mL (Robitussin AC), Lomotil, Motofen,
Lyrica, Parepectolin
Written Rx or OTC; must be 18 yo, ID must be showed, and dispensing must be
recorded
The Controlled Substances Act of 1970 - ANSControl over the coding of drugs and the
enforcement of these codes to the FDA and the Drug Enforcement Agency (DEA), a
part of the U.S. Department of Justice.
Pregnancy category A - ANSAdequate studies in pregnant women have not
demonstrated a risk to the fetus in the first trimester of pregnancy, and there is no
evidence of risk in later trimesters.
Pregnancy category B - ANSAnimal studies have not demonstrated a risk to the fetus
but there are no adequate studies in pregnant women.
Pregnancy category C - ANSAnimal studies have shown an adverse effect on the fetus
but there are no adequate studies in humans; the benefits from the use of the drug in
pregnant women may be acceptable despite its potential risks, or there are no animal
reproduction studies and no adequate studies in humans.
Pregnancy category D - ANSThere is evidence of human fetal risk, but the potential
benefits from the use of the drug in pregnant women may be acceptable despite its
potential risks.
Pregnancy category X - ANSStudies in animals or humans demonstrate fetal
abnormalities or adverse reaction; reports indicate evidence of fetal risk. The risk of use
in a pregnant woman clearly outweighs any possible benefit.
Pharmacotherapeutics - ANSclinical pharmacology—the branch of pharmacology that
deals with drugs; chemicals that are used in medicine for the treatment, prevention, and
diagnosis of disease in humans
Pharmacodynamics - ANSThe process by which a medication works on the body.
COMPLETE SOLUTIONS
Generic drugs - ANSdrugs sold by their generic name; not brand (or trade) name
products
Brand name - ANSname given to a drug by the pharmaceutical company that
developed it; also called a trade name
Genetic drugs vs Brand name - ANSOnce the patent on a brand name runs out
manufactures develop genetic drugs which are intended work on in the same way
(quality, dosage, strength, and route of administration).
The bioavailability of the generic drugs may differ from the brand name. This is why
providers might specify "dispense as written" so brand name product may use
especially in drugs that have narrow safety margins.
Control substance - (C-I) Schedule I - ANSHigh abuse potential and no accepted
medical use (heroin, marijuana, LSD)
Control substance - (C-II) Schedule II - ANSHigh abuse potential with severe
dependence liability (narcotics, amphetamines, and barbiturates)
Example: Cocaine, methamphetamines, methadone, Dilaudid, Demerol, Oxycodone,
Fentanyl, Morphine, Adderall, Ritalin, Dexedrine.
Written prescription only, no refills
Control substance - (C-III) Schedule III - ANSLess abuse potential than schedule II
drugs and moderate dependence liability (nonbarbiturate sedatives, nonamphetamine
stimulants, limited amounts of certain narcotics)
< 15 mg hydrocodone per dosage unit (Vicodin) ; < 90 mg of codeine p3er dosage unit
(Tylenol w/ codeine); ketamine; anabolic steroids; testosterone
Written/Oral Rx that expired w/n 6mos. No more than 5 refills.
, Control substance - (C-IV) Schedule IV - ANSLess abuse potential than schedule III and
limited dependence liability (some sedatives, antianxiety agents, and nonnarcotic
analgesics)
Examples: Xanax, Soma, Valium, Ativan, Talwin, Ambien
Written/Oral Rx that expires w/n 6 mons. No more than 5 refills.
Control substance - (C-V) Schedule V - ANSLimited abuse potential
Cough suppressants < 200 mg codeine/100 mL (Robitussin AC), Lomotil, Motofen,
Lyrica, Parepectolin
Written Rx or OTC; must be 18 yo, ID must be showed, and dispensing must be
recorded
The Controlled Substances Act of 1970 - ANSControl over the coding of drugs and the
enforcement of these codes to the FDA and the Drug Enforcement Agency (DEA), a
part of the U.S. Department of Justice.
Pregnancy category A - ANSAdequate studies in pregnant women have not
demonstrated a risk to the fetus in the first trimester of pregnancy, and there is no
evidence of risk in later trimesters.
Pregnancy category B - ANSAnimal studies have not demonstrated a risk to the fetus
but there are no adequate studies in pregnant women.
Pregnancy category C - ANSAnimal studies have shown an adverse effect on the fetus
but there are no adequate studies in humans; the benefits from the use of the drug in
pregnant women may be acceptable despite its potential risks, or there are no animal
reproduction studies and no adequate studies in humans.
Pregnancy category D - ANSThere is evidence of human fetal risk, but the potential
benefits from the use of the drug in pregnant women may be acceptable despite its
potential risks.
Pregnancy category X - ANSStudies in animals or humans demonstrate fetal
abnormalities or adverse reaction; reports indicate evidence of fetal risk. The risk of use
in a pregnant woman clearly outweighs any possible benefit.
Pharmacotherapeutics - ANSclinical pharmacology—the branch of pharmacology that
deals with drugs; chemicals that are used in medicine for the treatment, prevention, and
diagnosis of disease in humans
Pharmacodynamics - ANSThe process by which a medication works on the body.
